Navigation Links
CNIO researchers identify a new gene that is essential for nuclear reprogramming
Date:6/5/2013

Researchers are still fascinated by the idea of the possibility of reprogramming the cells of any tissue, turning them into cells with the capacity to differentiate into cells of a completely different type pluripotent cellsand they are still striving to understand how it happens.

A group from the Spanish National Cancer Research Centre (CNIO), headed by researcher Ralph P. Schneider, from the Telomeres and Telomerase Group led by María A. Blasco, publishes this week an article in Nature Communications on the discovery of a new gene called TRF1 that is essential for nuclear reprogramming.

It is also known that TRF1 is indispensable for protecting telomeres, the ends of chromosomes. Existing evidence suggests that the length of telomeres and pluripotencythe capacity of a cell to differentiate into multiple cell typesare related. Pluripotent cells, for example, have very long telomeresa previous finding at CNIObut until now no protective protein for the telomeres had been found that was essential for pluripotency.

To investigate the connection between telomeres and pluripotency, researchers generated a 'reporter' mouse: they linked together the TRF1 gene and the gene coding for a green fluorescent protein and created a lineage of mice carrying this new genetic baggage. In these animals, the green fluorescent protein acts as a label to show expression of TRF1.

They discovered that TRF1 is an excellent marker for stem cells, both in adult stem cellsthose that are found in tissues and the different organs of the bodyand embryonic stem cells. It is also the case with 'induced pluripotent' stem cells (iPS cells), which are pluripotent cells that come from artificially reprogrammed specialised cells.

In the case of tissues, the authors write: "TRF1 distinguishes adult stem cells and is indispensable for their functioning". The discovery is useful for both identifying and eventually isolating the stem cell popul
'/>"/>

Contact: Press Office
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers develop a faster method to identify Salmonella strains
2. Researchers document acceleration of ocean denitrification during deglaciation
3. Researchers design sensitive new microphone modeled on fly ear
4. Researchers help threatened wheat crops in Asia, Africa
5. U of A medical researchers ID genetic marker for sporadic breast cancer
6. UCI researchers find sea anemone venom-derived compound effective in anti-obesity studies
7. MU researchers develop radioactive nanoparticles that target cancer cells
8. Genetic predictors of postpartum depression uncovered by Hopkins researchers
9. U of M researchers develop model for better testing, targeting of MPNST
10. Widespread but neglected disease a health threat in Africa, Virginia Tech researchers say
11. Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... conventional thinking on how the bowel lining develops and, ... bowel cancer starts. , The researchers produced evidence that ... ,crypts, that are a feature of the bowel lining, ... cancer development, a controversial finding as scientists are still ... imaging technologies, Dr Chin Wee Tan and Professor Tony ...
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2New perspectives for development of an RSV vaccine 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... In a recent study to be published on April 27, ... Dr. Elliott Hazen and colleagues found that oceanographic and prey ... The research team from Duke University, Woods Hole, and the ... measured ocean features and distributions of prey off the east ...
... war, rape victims and other people who have seen horrific crimes ... brains? In a new study, UCLA life scientists report a discovery ... "I think we will be able to alter memories ... senior author, David Glanzman, a UCLA professor of integrative biology and ...
... definitive collection of thousands of approved drugs for clinical ... for additional uses of the drugs hoping to find ... that afflict 25 million Americans. The effort is coordinated ... (NCGC). "This is a critical step to explore ...
Cached Biology News:Identifying beaked whale foraging habitat in the tongue of the ocean, Bahamas 2Can traumatic memories be erased? 2Can traumatic memories be erased? 3Can traumatic memories be erased? 4Can traumatic memories be erased? 5Can traumatic memories be erased? 6NIH researchers create comprehensive collection of approved drugs to identify new therapies 2NIH researchers create comprehensive collection of approved drugs to identify new therapies 3NIH researchers create comprehensive collection of approved drugs to identify new therapies 4
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider ... with a team of researchers from Yale University’s School ... Collaborative to provide electronic questionnaire data collection through use ... started in May, aims to evaluate the impact of ... to and participation in urban agriculture to impact their ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
(Date:10/20/2014)... 20, 2014 The report “Pharmacy ... Systems, Packaging and Labeling Systems, Table-top Counters) by ... Global Forecasts & Trends to 2019” analyzes and ... in North America, Europe, Asia-Pacific, and the Rest ... tables and 30 figures spread through 300 pages ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... /PRNewswire-Asia-FirstCall/ -- Rodobo International,Inc. (OTC Bulletin Board: RDBO), one ... results for the second quarter and,first six months ended ... quarter financial highlights include: , ... was $6.3 million, an,increase of 19% compared to Q2 ...
... 18 Focusing on critical healthcare reform ... preventable adverse events, and responding to President ... will gather at the National Patient Safety ... fundamental shifts necessary to keep patients safe ...
... -- Global biomedical sciences companies,invested more than US$500 ... rides on,Singapore,s strong scientific fundamentals, with biomedical sciences ... The continued confidence in Singapore ... look to the fast growing Asian,market to fuel ...
Cached Biology Technology:Rodobo International, Inc. Reports Q2 and First Half of 2009 2Rodobo International, Inc. Reports Q2 and First Half of 2009 3Rodobo International, Inc. Reports Q2 and First Half of 2009 4Rodobo International, Inc. Reports Q2 and First Half of 2009 5Rodobo International, Inc. Reports Q2 and First Half of 2009 6Rodobo International, Inc. Reports Q2 and First Half of 2009 7Rodobo International, Inc. Reports Q2 and First Half of 2009 8Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22 2Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22 3Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 2Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 3Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 4Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 5